Iklan
Iklan
NEW
Prevenar 20

Prevenar 20

vaccine, pneumococcal

Manufacturer:

Pfizer
Concise Prescribing Info
Contents
Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)
Indications/Uses
Active immunization for the prevention of invasive disease, pneumonia & acute otitis media caused by Strep pneumoniae in infants 6 wk to 15 mth; invasive disease & pneumonia caused by Strep pneumoniae in individuals 18 to 64 yr.
Dosage/Direction for Use
IM 0.5 mL (1 dose). Individual 18 to 64 yr Single-dose. Infant 6 wk to 15 mth Primary infant series consisting 3 doses w/ 1st dose given at 2 mth (may be given as early as 6 wk) & w/ at least 4 wk interval between doses followed by 4th (booster) dose to be administered between 11-15 mth.
Contraindications
Hypersensitivity to pneumococcal polysaccharide conjugate vaccine or diphtheria toxoid.
Special Precautions
Appropriate medical treatment & supervision must be ready in case of rare anaphylactic reaction following vaccination. Do not inj intravascularly. Postpone vaccination in individuals suffering from acute severe febrile illness. Individuals w/ thrombocytopenia or bleeding disorder; carefully evaluate risk of bleeding in patients w/ coagulation disorders before vaccination. Only protects against Strep pneumoniae serotypes included in vaccine & will not protect against other microorganisms that cause invasive disease, pneumonia or otitis media; may not protect all individuals receiving vaccine from pneumococcal disease. May reduce immune responses to Prevenar 20 in some individuals w/ altered immunocompetence. May reduce Ab response to active immunization in individuals w/ impaired immune response due to immunosuppressive therapy, genetic defect, HIV infection or other causes. May temporarily affect ability to drive or use machines. Pregnancy & lactation. Potential risk of apnea in preterm infants; consider monitoring for at least 48 hr after vaccination for preterm infant ≤28 wk of gestation who remain hospitalized at time of administration. Infant <6 wk.
Adverse Reactions
Vaccination-site pain/tenderness. Fever, vaccination-site erythema, induration/swelling. Adult: Headache; muscle & joint pain; fatigue. Infant: Decreased appetite; irritability; drowsiness/increased sleep. Diarrhea; fever >38.9℃.
Drug Interactions
Administer different inj vaccines at different vaccination sites. Do not mix w/ other vaccines/products in the same syringe.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07AL02 - pneumococcus, purified polysaccharides antigen conjugated ; Belongs to the class of pneumococcal bacterial vaccines.
Presentation/Packing
Form
Prevenar 20 susp for inj 51 μg/0.5 mL
Packing/Price
((single-dose pre-filled syringe)) 0.5 mL x 1's
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan